Global Pharmacokinetic Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Pharmacokinetic Testing
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Pharmacokinetic Testing by Type
  • 1.3.1 Overview: Global Pharmacokinetic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Pharmacokinetic Testing Consumption Value Market Share by Type in 2022
  • 1.3.3 Oral Dissolution Testing (FDC)
  • 1.3.4 Intravenous Titration Test (IVRT)
  • 1.3.5 Cell Line In-house Testing (ICR)
• 1.4 Global Pharmacokinetic Testing Market by Application
  • 1.4.1 Overview: Global Pharmacokinetic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Research Institutions
• 1.5 Global Pharmacokinetic Testing Market Size & Forecast
• 1.6 Global Pharmacokinetic Testing Market Size and Forecast by Region
  • 1.6.1 Global Pharmacokinetic Testing Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Pharmacokinetic Testing Market Size by Region, (2018-2029)
  • 1.6.3 North America Pharmacokinetic Testing Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Pharmacokinetic Testing Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Pharmacokinetic Testing Market Size and Prospect (2018-2029)
  • 1.6.6 South America Pharmacokinetic Testing Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Pharmacokinetic Testing Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Pharmaceutical Product Development, LLC
  • 2.1.1 Pharmaceutical Product Development, LLC Details
  • 2.1.2 Pharmaceutical Product Development, LLC Major Business
  • 2.1.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product and Solutions
  • 2.1.4 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Pharmaceutical Product Development, LLC Recent Developments and Future Plans
• 2.2 Charles River Laboratories International, Inc.
  • 2.2.1 Charles River Laboratories International, Inc. Details
  • 2.2.2 Charles River Laboratories International, Inc. Major Business
  • 2.2.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product and Solutions
  • 2.2.4 Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Charles River Laboratories International, Inc. Recent Developments and Future Plans
• 2.3 Creative Bioarray
  • 2.3.1 Creative Bioarray Details
  • 2.3.2 Creative Bioarray Major Business
  • 2.3.3 Creative Bioarray Pharmacokinetic Testing Product and Solutions
  • 2.3.4 Creative Bioarray Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Creative Bioarray Recent Developments and Future Plans
• 2.4 Certara, L.P.
  • 2.4.1 Certara, L.P. Details
  • 2.4.2 Certara, L.P. Major Business
  • 2.4.3 Certara, L.P. Pharmacokinetic Testing Product and Solutions
  • 2.4.4 Certara, L.P. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Certara, L.P. Recent Developments and Future Plans
• 2.5 Evotec AG
  • 2.5.1 Evotec AG Details
  • 2.5.2 Evotec AG Major Business
  • 2.5.3 Evotec AG Pharmacokinetic Testing Product and Solutions
  • 2.5.4 Evotec AG Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Evotec AG Recent Developments and Future Plans
• 2.6 Pacific BioLabs
  • 2.6.1 Pacific BioLabs Details
  • 2.6.2 Pacific BioLabs Major Business
  • 2.6.3 Pacific BioLabs Pharmacokinetic Testing Product and Solutions
  • 2.6.4 Pacific BioLabs Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Pacific BioLabs Recent Developments and Future Plans
• 2.7 GVK Biosciences Private Limited
  • 2.7.1 GVK Biosciences Private Limited Details
  • 2.7.2 GVK Biosciences Private Limited Major Business
  • 2.7.3 GVK Biosciences Private Limited Pharmacokinetic Testing Product and Solutions
  • 2.7.4 GVK Biosciences Private Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 GVK Biosciences Private Limited Recent Developments and Future Plans
• 2.8 SGS SA
  • 2.8.1 SGS SA Details
  • 2.8.2 SGS SA Major Business
  • 2.8.3 SGS SA Pharmacokinetic Testing Product and Solutions
  • 2.8.4 SGS SA Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 SGS SA Recent Developments and Future Plans
• 2.9 LGC Limited
  • 2.9.1 LGC Limited Details
  • 2.9.2 LGC Limited Major Business
  • 2.9.3 LGC Limited Pharmacokinetic Testing Product and Solutions
  • 2.9.4 LGC Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 LGC Limited Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Pharmacokinetic Testing Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Pharmacokinetic Testing by Company Revenue
  • 3.2.2 Top 3 Pharmacokinetic Testing Players Market Share in 2022
  • 3.2.3 Top 6 Pharmacokinetic Testing Players Market Share in 2022
• 3.3 Pharmacokinetic Testing Market: Overall Company Footprint Analysis
  • 3.3.1 Pharmacokinetic Testing Market: Region Footprint
  • 3.3.2 Pharmacokinetic Testing Market: Company Product Type Footprint
  • 3.3.3 Pharmacokinetic Testing Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Pharmacokinetic Testing Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Pharmacokinetic Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Pharmacokinetic Testing Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Pharmacokinetic Testing Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Pharmacokinetic Testing Consumption Value by Type (2018-2029)
• 6.2 North America Pharmacokinetic Testing Consumption Value by Application (2018-2029)
• 6.3 North America Pharmacokinetic Testing Market Size by Country
  • 6.3.1 North America Pharmacokinetic Testing Consumption Value by Country (2018-2029)
  • 6.3.2 United States Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Pharmacokinetic Testing Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Pharmacokinetic Testing Consumption Value by Type (2018-2029)
• 7.2 Europe Pharmacokinetic Testing Consumption Value by Application (2018-2029)
• 7.3 Europe Pharmacokinetic Testing Market Size by Country
  • 7.3.1 Europe Pharmacokinetic Testing Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 7.3.3 France Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Pharmacokinetic Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Pharmacokinetic Testing Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Pharmacokinetic Testing Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Pharmacokinetic Testing Market Size by Region
  • 8.3.1 Asia-Pacific Pharmacokinetic Testing Consumption Value by Region (2018-2029)
  • 8.3.2 China Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 8.3.5 India Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Pharmacokinetic Testing Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Pharmacokinetic Testing Consumption Value by Type (2018-2029)
• 9.2 South America Pharmacokinetic Testing Consumption Value by Application (2018-2029)
• 9.3 South America Pharmacokinetic Testing Market Size by Country
  • 9.3.1 South America Pharmacokinetic Testing Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Pharmacokinetic Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Pharmacokinetic Testing Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Pharmacokinetic Testing Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Pharmacokinetic Testing Market Size by Country
  • 10.3.1 Middle East & Africa Pharmacokinetic Testing Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Pharmacokinetic Testing Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Pharmacokinetic Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Pharmacokinetic Testing Market Drivers
• 11.2 Pharmacokinetic Testing Market Restraints
• 11.3 Pharmacokinetic Testing Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Pharmacokinetic Testing Industry Chain
• 12.2 Pharmacokinetic Testing Upstream Analysis
• 12.3 Pharmacokinetic Testing Midstream Analysis
• 12.4 Pharmacokinetic Testing Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source